Heart support device with directional flow assistance
By introducing the chamber body, dynamic volume body and directional flow structure into the cardiac support device, combined with the foldable and expandable support structure, the problems of low circulation assist efficiency and high risk of cardiac wall damage in the prior art are solved, and the problem of low circulation assist efficiency and high risk of cardiac wall damage in the prior art is achieved. More efficient blood flow and lower invasive operation.
Patent Information
- Application Number
- CN202410918627.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2018-07-27
- Filing Date
- 2019-07-26
- Publication Date
- 2024-11-15
AI Technical Summary
Existing cardiac support devices fail to effectively simulate the blood flow efficiency of natural heart movement when providing circulatory assistance, especially in the case of thinning of the heart wall or scarring, and have a high risk of percutaneous cardiovascular intervention.
A cardiac support device is designed, including a chamber body and a dynamic volume body, which is in fluid communication with the chamber through a catheter. The dynamic volume body can expand or contract to change the interior volume of the chamber and guide blood to the main through a directional flow structure. Arterial valves, which adopt foldable and expandable support structures to minimize invasiveness, combine vortex-induced structures and venturi to optimize blood flow.
The device can more closely simulate natural heart blood flow, improve circulation assistance efficiency, reduce the risk of damage to the heart wall, and guide blood more effectively to the aortic valve through the directional flow structure, enhancing the natural function of circulation assistance.
Smart Images

Figure CN118949259A_ABST
Abstract
Description
Field of the Invention
[0001] The present invention relates to cardiac support devices and, more particularly, to intraventricular assist pumping devices having directional flow for circulatory assistance. background
[0002] After cardiac shock or due to chronic heart failure, it may be necessary to provide temporary mechanical circulatory assistance. Circulatory assistance can be provided by introducing a balloon into the patient's ventricle and causing the balloon to expand and contract during diastole and systole, respectively. An external pumping unit is typically used to inflate the balloon with a drive fluid (e.g., a neutral drive gas or liquid). The cyclic expansion and contraction of the intraventricular balloon displaces the blood within the chamber and provides circulatory assistance to the patient.
[0003] Expandable intraventricular devices are known in the art.
[0004] US Patent Publication US2013 / 184515 A1 describes an intraventricular balloon device comprising an elongated flexible catheter having a proximal end and a distal end. An inflatable balloon is provided near the distal end, and the balloon can be brought into its deflected state, allowing access to, for example, the left ventricle. An additional balloon can be provided on the catheter to be accommodated in an appropriate blood vessel (e.g., the descending aorta).
[0005] International patent publication WO2016 / 001218 describes a cardiac support device for circulatory assistance having an internal member configured to be disposed within a cardiac cavity. The device comprises a dynamic volume body that is capable of cyclically expanding and contracting with a natural (or altered) heart rhythm. The internal member has a substantially rigid wall reinforcement portion and a dynamic member that is arranged to engage an inner wall surface of the heart in operation, the dynamic member being expandable to assist the pumping action of the heart.
[0006] Although the effect of both of the above systems is to remove the remaining volume of blood from the heart chambers, such removal devices do not achieve the efficiency of natural heart movement.
[0007] There is therefore a need for an improved circulatory assist device. Summary of the invention
[0008] The present invention seeks to provide an improved cardiac support device that can be implanted in a heart chamber with a minimally invasive procedure and is suitable for treating cardiogenic shock and / or chronic heart failure due to weakened heart walls or scarring of heart tissue, and those who are at higher risk for percutaneous cardiovascular intervention (PCI). More specifically, the present invention seeks to improve upon existing devices by providing a directional flow structure to direct blood flow toward, for example, the aortic valve when the pump is placed in the left ventricle.
[0009] According to the present invention, a cardiac support device for circulatory assistance is provided, which includes a chamber body, the chamber body defining a chamber having an internal volume configured to be filled with blood, the chamber body having a first opening, wherein the dimensions of the chamber body and the first opening are designed to be disposed in a chamber of a human heart. The dynamic volume body is configured to expand or contract to alternately increase and decrease the internal volume of the chamber. A catheter including at least one cavity is provided to be fluidically connected to the dynamic volume body and is arranged to deliver fluid to the dynamic volume body to expand the dynamic volume body. A directional flow structure is also provided to direct the blood flow away from the chamber in a direction substantially aligned with the direction in which the catheter extends. Since the device is configured to be placed in the heart with the catheter extending through the aortic valve, by providing a directional flow device that directs the discharge fluid to flow along the axis of the catheter, the present invention provides directional flow toward the aortic valve in a manner that more closely reflects the natural flow of blood in the heart than known devices.
[0010] The directional flow structure can be configured in different ways. For example, the directional flow structure can include a restricted opening, such as a neck at the proximal end of the device, which is relatively narrow compared to the chamber. The restricted opening can include an elongated tube, a tapered neck, or a venturi tube (including a tapered inlet cone and a tapered outlet cone). The walls of the neck can be substantially parallel to each other.
[0011] Alternatively or additionally, the directed flow component may include a structure that imparts swirl in the fluid flow exiting the aperture. The swirl inducing structure may include static or movable impeller blades, a torsional balloon that expands with a torsional motion within a chamber, or a combination thereof.
[0012] The dynamic volume body can also be configured in different ways. For example, the dynamic volume body can include an expandable membrane disposed within the chamber, which is configured to expand within the chamber, thereby displacing a volume of blood within the chamber through the hole. In such an embodiment, the expandable membrane can include a balloon having a membrane that is substantially more flexible relative to the wall of the chamber. This ensures that when the balloon is expanded, it displaces blood within the chamber while the chamber maintains a stable expanded configuration.
[0013] The directed flow structure may include a restricted opening providing a constriction at the first opening.
[0014] The cardiac support device may optionally include a support structure configured to support the chamber body in an expanded configuration.
[0015] In at least some embodiments, the cardiac support device can be collapsible to allow the device to be inserted into a heart chamber in a minimally invasive manner. The support structure can be expandable and can be provided in fluid communication with at least one lumen of the catheter to allow expansion of the support structure.
[0016] In at least some embodiments, the support structure can include a support formed from an elastic material that is biased into a second configuration and can expand from a first configuration in which the chamber body has a first internal volume to a second configuration in which the chamber body includes a second internal volume that is larger than the first internal volume.
[0017] Optionally, the dynamic volume body is configured to expand the support structure from the first configuration to the second configuration, thereby increasing the internal volume of the chamber.
[0018] In at least some embodiments, the dynamic volume body may include an expandable balloon disposed within the chamber. Advantageously, the balloon may be a toroidal balloon.
[0019] The chamber body may extend from a proximal end where the first hole is located to a distal end opposite the proximal end, wherein the balloon is disposed at the distal end of the chamber body. The balloon may be configured to expand proximally to impart directional flow to blood leaving the chamber.
[0020] The chamber body may also be provided with one or more additional openings disposed at the distal end of the chamber, away from the first opening. The additional openings at the distal end of the chamber may provide limited recoil from the distal end of the chamber, which may minimize the risk of blood pooling and clotting at the distal end of the chamber.
[0021] Advantageously, the additional openings account for approximately 5%-10% (eg 5%) of the cross-sectional flow area into / out of the chamber, whereas the first openings may account for approximately 90-95% (eg 95%).
[0022] Additionally or alternatively, the chamber wall may include one or more additional side openings configured to provide additional access for blood to enter the chamber interior.
[0023] The additional opening may be configured as a one-way flow opening that allows flow into the interior volume of the chamber and prevents or inhibits flow out of the chamber.
[0024] In at least one set of embodiments of the invention, the apparatus may further comprise a swirl inducing arrangement.The swirl inducing arrangement may be configured to impart a spiral or swirling flow to the fluid exiting the chamber through the outlet opening.
[0025] The swirl inducing structure may include a plurality of static vanes disposed within the restricted opening.
[0026] In another set of embodiments, which may be implemented independently of or in combination with the above-described embodiments, the chamber body may include a helical support structure configured to allow the chamber body to helically fold.
[0027] In yet another set of embodiments that can be implemented independently of or in combination with the above embodiments, the directional flow structure can include a venturi tube. This can maintain a stable directional flow of blood toward the aorta when the device is in use.
[0028] In another set of embodiments that can be implemented independently of the above embodiments or in combination with the above embodiments, the chamber body can include a longitudinal axis A, and the restricting opening can include a tube extending along a second axis, and wherein the first axis and the second axis are not coaxial. This arrangement can allow the chamber body to rest against the heart wall with the outlet positioned toward the aorta. This arrangement can also improve the directional flow of blood through the aortic valve. As described above, when the heart support device is placed in the left ventricle, the directional flow structure is configured to direct the blood flow toward the aortic valve. This can improve the efficiency of the device because it more closely replicates the blood flow seen during unimpaired natural heart function. In addition, because the heart support device is placed in the heart chamber, the hole is located in the heart chamber, in front of the aortic valve, and interference with the aortic valve (which may cause damage) is minimized. BRIEF DESCRIPTION OF THE DRAWINGS
[0029] The present invention will now be described more fully with reference to a number of exemplary embodiments as shown in the accompanying drawings, in which:
[0030] Figure 1 An in vivo cardiac support device according to the present invention is shown;
[0031] Figures 2A-2D The operation of a cardiac support device according to an embodiment of the present invention is shown;
[0032] Figure 3A A first balloon configuration suitable for use with an embodiment of the present invention is shown;
[0033] Figure 3B A second balloon configuration suitable for use with embodiments of the present invention is shown;
[0034] Figure 3C A third balloon configuration suitable for use with embodiments of the present invention is shown;
[0035] Figure 4 A cardiac support device including a directional flow assembly according to an embodiment of the present invention is shown;
[0036] Figure 5 A cardiac support device including a directional flow assembly according to an embodiment of the present invention is shown;
[0037] Figures 6A-6D Shows the application Figure 5 Operation of the valve arrangement of the illustrated embodiment;
[0038] Figure 7 A cardiac support device including a directional flow assembly according to another embodiment of the present invention is shown;
[0039] Figure 8 A cardiac support device including a directional flow assembly according to another embodiment of the present invention is shown;
[0040] Fig. 9 An in vivo cardiac support device including an angled directional flow assembly is shown.
[0041] DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS
[0042] Figure 1 An exemplary embodiment of a cardiac support device for providing circulatory assistance to a patient is shown. Figure 1 In the illustrated embodiment, the cardiac support device is positioned within the left ventricle LV. Figure 1 As shown, the cardiac support device according to the present invention comprises a chamber 10 which defines an internal volume and has at least one hole 12 for fluid communication between the internal volume of the chamber 10 and a volume outside the chamber 10. Figure 1 As shown, the dimensions of the chamber 10 are such that the chamber 10 and the aperture 12 can be disposed within a chamber of a human heart (in the above case, the left ventricle LV).
[0043] In the left ventricle embodiment, the device may have a maximum outer diameter of 2 cm to 6 cm, more specifically 2 cm to 4 cm. In one example, the chamber has a maximum outer diameter of 2.5 cm at its widest point.
[0044] The length of the device (extending from the aperture to the end opposite the aperture) may be 4 cm to 10 cm, more particularly 5 cm to 8 cm. In one embodiment, the length of the device is 5 cm.
[0045] Those skilled in the art will appreciate that the length of the device can be adjusted according to the needs of the individual patient. For example, for many patients who require circulatory assistance, the heart wall may be damaged to some extent, resulting in a significant increase in the internal volume of the left ventricle compared to a healthy individual. The device can be mapped to the individual patient according to individual needs. Optionally, a range of sizes (small, medium, large) can be made and the appropriate size is selected for each individual.
[0046] The support device also includes at least one dynamic volume body 14, which is configured to expand and / or contract to alternately increase and decrease the available internal volume of the chamber 10 (i.e., the volume within the chamber 10 that can be filled with blood). A catheter 16 including at least one fluid lumen 18 is in fluid communication with the dynamic volume body 14 and is configured to deliver a fluid (e.g., a liquid or a gas, such as helium) to the dynamic volume body 14 to expand and / or contract the body 14. A directional flow structure 20 is also provided to direct the blood flow away from the chamber 10 in a direction substantially aligned with the direction in which the catheter extends.
[0047] In addition to displacing a volume of blood within the chamber due to the cyclic increase / decrease in available volume of the chamber 10, the directional flow structure 20 advantageously directs the displaced blood in the direction of the aortic valve (i.e., in a manner that more closely resembles the natural function of the heart). By providing a directional flow structure to direct blood flow toward the aortic valve, the blood flow generated by the device more closely mimics the blood flow seen during unimpaired native heart function, thereby improving the efficiency of the supported heart.
[0048] The directional flow structure can be implemented in different ways. For example, the directional flow structure 20 can include a restricted opening at the proximal end (e.g., neck) of the chamber 10. The proximal end of the chamber 10 is the end from which the catheter 16 extends. The restricted opening 22 has a cross-sectional area smaller than the cross-sectional area of the chamber 10, and a constriction is provided at the first opening. Advantageously, the diameter of the restricted opening 22 is less than (or equal to) the diameter of the aorta (typically 30% or less of the body diameter; in some instances, 0.3 cm to 2 cm, more specifically 0.3 cm to 1.5 cm, more specifically 0.5 cm). Advantageously, the restricted opening 22 is centered on the catheter 16 and includes a straight-sided tube or pipe. The tube can be cylindrical (with parallel walls) or taper toward the opening. In some embodiments, a venturi tube forms the restricted opening, as described in more detail below.
[0049] Directional flow may also be provided by structures that provide pumping pulses in the direction of the aortic valve. Embodiments of the invention including different directional flow structures will be described in more detail below.
[0050] The cardiac support device may also include a support structure 24 configured to support the chamber 10 in an expanded configuration. The support structure 24 may hold the chamber 10 in a stable position so that a balloon or other expandable member may be inflated within the chamber 10 to reduce the available volume (thus forcing blood through the directional flow structure).
[0051] To allow the support device to be introduced into the heart chamber by a minimally invasive procedure, the support structure 24 can be collapsible. This can allow the device to be introduced into the left ventricle through the aorta (or another natural cavity). The support structure can be biased into an expanded position and maintained in a collapsed position by a catheter or other tool during insertion. As an example, the support structure 24 can include a shape memory material, such as in the form of a collapsible stent formed of nitinol, or another shape memory material.
[0052] Once removed from the catheter, support structure 24 can return to its expanded configuration.
[0053] Optionally, support structure 24 may include an expandable stent that can be expanded by supplying fluid or gas to the stent. In other words, in at least some embodiments, support structure 24 is expandable. In such embodiments, support structure 24 may be provided in fluid communication with at least one lumen of catheter 16 to allow support structure 24 to expand after entering the heart chamber.
[0054] Once the chamber has been expanded to its expanded position, the dynamic volume body can act as a displacement body disposed within the chamber and is expandable to fill an increasing proportion of the interior volume of the chamber 10. Because the displacement body (e.g., balloon 26) is disposed within the chamber, when the balloon is inflated, it displaces blood within the chamber, thereby forcing the blood to flow through the orifice 12 toward the aortic valve.
[0055] The support structure 24 may include a stent formed of an elastic material that is biased into a second configuration and expandable from a first configuration in which the chamber body 10 has a first interior volume to a second configuration in which the chamber body 10 includes a second interior volume that is greater than the first interior volume. The elastic material may include an elastic or shape memory material that is biased into an expanded configuration and may be compressed or collapsed when the device is passed through a natural cavity into the ventricle. In these embodiments, the dynamic volume body 14 may be configured to expand the support structure 24 from the first configuration to the second configuration, thereby increasing the interior volume of the chamber 10.
[0056] Reference again Figure 2A, the dynamic volume body 12 may include an expandable balloon 26 disposed within the chamber 10. The balloon 26 is disposed within the chamber body 10, which may take the form of a cup 28. Once expanded to the expanded configuration, the cup 28 is relatively rigid compared to the balloon 26. The balloon 26 is at least partially formed by a membrane defining an internal volume, which is configured to expand when the fluid (e.g., liquid or gas) within the balloon 28 increases. The membrane may be formed of an elastic material configured to stretch when the internal volume is filled with air, or the membrane may be substantially inelastic. The cup 28 may be formed by an expandable support 30 having a sidewall 32, which defines the volume of the chamber 10. The sidewalls of the cup may be formed in a manner described in WO2016 / 001218A1 (which is incorporated herein by reference in its entirety). However, it will be appreciated by those skilled in the art that other cup structures are possible in light of the present disclosure.
[0057] Figure 2B-2D The configuration of a "balloon-in-cup" type heart support device is shown at different stages. Figure 2A In FIG. 1 , the cup 28 is in its expanded configuration within the heart chamber. The balloon 26 is empty and the interior volume of the chamber 10 is filled with blood B. Figure 2B In the embodiment, the balloon 26 is expanded by filling the balloon 26 with gas or liquid. When the balloon 26 is expanded, the volume it occupies within the chamber 10 increases, and the blood B is displaced from the internal volume of the chamber 10 and forced through the hole 12 at the proximal end of the chamber. Figure 2D As shown, this allows blood to leave chamber 10 through the holes and directional flow structure, thereby directing blood flow toward aortic valve AV. As balloon 26 expands, the volume it occupies within cup 28 gradually increases, thereby displacing blood filling chamber 10 and forcing blood to flow from chamber 10 through directional flow structure and holes 12 toward aortic valve AV.
[0058] The balloon 26 can be configured in a variety of different ways. For example, the balloon 26 can include a balloon 26 that is free to expand in all directions (in the manner of a conventional balloon). When the balloon is inflated within the chamber body 10, the available internal volume of the chamber is reduced and blood is forced from the chamber 10 through the aperture 12. Optionally, and as Figure 3A As shown, the balloon 26 may include a flexible elastic membrane fixed within a cup 28 to form a sealed cavity that can be filled with an inflation fluid. The cup and membrane combination of the embodiment can be formed in a similar manner to the device described in WO2016 / 001218A1, but the wall of the cup forming the chamber body 10 should extend beyond the membrane toward the restricted opening that provides directional flow control. Advantageously, the balloon 26 is provided at the end of the chamber body 10 opposite to the first opening 12.
[0059] like Figure 3A As shown, the cup 28 can integrate the distal portion of the catheter 16 with a plurality of fluid ports 27 into its sidewall. The openings 27 are provided in fluid communication with the interior of the balloon 26 and are configured to fill the sealed cavity of the balloon 26. Figure 3B As shown, the balloon can be inflated and deflated through a catheter that is not integrated into the side wall. Figure 3C As shown, the balloon 26 may include an annular (or donut-shaped) balloon 26. The annular balloon 26 may be configured to be centrally filled from a plurality of openings 27 in the catheter 16. This may provide symmetrical filling of the annular balloon 26.
[0060] like Figure 3A and 3B As shown, the chamber 10 can extend from the proximal end where the first hole 22 is located to the distal end opposite to the proximal end. The balloon 28 is disposed at the distal end of the chamber 10 and is configured to expand toward the proximal end. Figure 3A and 3B In both embodiments shown, balloon 28 is configured to cause the flexible membrane to expand (when filled) in a direction toward the direction in which catheter 16 extends. Extension of the flexible membrane in this direction can be configured to cause pulsations that further assist in directional flow control of blood exiting chamber 10 through aperture 12. In other words, balloon 28 (or balloons) can be configured to expand asymmetrically, expanding from the distal end of chamber 10 to the proximal end.
[0061] Now back to Figure 4 , the chamber 10 may also be provided with an additional opening, which is disposed at the distal end of the chamber 10, away from the first opening. The additional opening 30 provides additional fluid communication between the internal volume of the chamber 10 and the volume outside the chamber 10. Advantageously, when the available volume of the chamber 10 is reduced, the additional opening 30 allows blood from the lower part of the chamber 10 to surge through the additional opening 30. By providing an additional opening to surge blood from the lower part of the chamber 10, the risk of clot formation within the chamber 10 is reduced. In addition, the blood flow through the additional opening 30 surges blood from the area A between the device and the heart wall, further reducing the risk of clot formation in the LV. Since the main function of the heart support device is to provide circulatory assistance, the additional opening 30 should be smaller than the first opening 12, so that most of the blood discharged from the chamber 10 is discharged toward the aorta through the first opening 12. In some embodiments, the additional opening 30 is responsible for less than 30% of the cross-sectional flow area entering / leaving the chamber 10, while the first opening 12 is responsible for 70% or more. Advantageously, additional openings 30 account for approximately 5%-10% (e.g. 5%) of the cross-sectional flow area into / out of chamber 10, while first openings 12 account for approximately 90%-95% (e.g. 95%). Those skilled in the art will appreciate that this ratio may be modified to suit a particular application / particular patient need.
[0062] Now go to Figure 5 , chamber 10 may include one or more additional side openings 32 configured to provide additional inlets for blood to enter the interior of chamber 10. Additional side openings 32 may include a one-way valve structure configured to allow fluid to flow into chamber 10 through opening 32 (and prevent flow in the opposite direction). By providing additional side openings 32 in the wall of chamber 10, the heart support device can draw blood into chamber 10 as the available volume increases from a location within the heart chamber away from the aortic valve. This can prevent undesirable negative pressure behind the aortic valve.
[0063] The additional side opening 32 may be configured to self-seal when the pressure within the chamber 10 increases as the available volume decreases. Figures 6A-6D As shown, additional side openings 32 may be formed at the intersection of multiple overlapping panels 34. The panels 34 are arranged in a circular overlapping arrangement, with the leading edge 34a of each panel 34 overlapping the trailing edge 34b of the next panel 34. Fig. 6A and 6B As shown, as the available internal volume of the chamber 10 increases, the pressure in the chamber 10 decreases, and blood is drawn in through the opening 32 between the panels 34. However, as the available internal volume of the chamber 10 decreases, the pressure in the chamber 10 forces the overlapping portions of the panels 34 to contact each other, thereby sealing the opening 32 closed (see FIG. Figure 6C ). Therefore, if Fig.6D As shown, the blood in the chamber 10 is forced out of the chamber 10 through the opening 12. Figures 6A to 6D As shown, the panel 34 may be supported by a plurality of ribs that provide a support structure 24 .
[0064] As Figures 6A-6D In an alternative to the panel arrangement shown in FIG. 1 , additional openings 32 (see, e.g., Figure 5 ) may include a conventional one-way valve. Those skilled in the art will appreciate that other configurations that allow one-way flow through the opening 32 may also be employed. In other words, the additional opening may be configured as a one-way flow opening 32 that allows flow into the interior volume of the chamber 10 and prevents or inhibits flow out of the chamber 10.
[0065] To further enhance directional flow out of the chamber 10 toward the aortic valve, the directional flow structure 20 may also include a swirl inducing arrangement. Figure 7 As shown, the swirl inducing structure may include a plurality of static vanes 36 (eg, a static impeller arrangement) arranged within the restricted opening 22 and configured to induce swirl in the fluid flowing over the vanes.
[0066] In other embodiments, vortex or spiral flow toward the aorta can be induced by the manner in which balloon 26 is expanded. For example, balloon 26 can be wrapped or folded within the chamber so that it twists when expanded to create a vortex if flowing through the hole.
[0067] exist Figure 8 In the illustrated embodiment, the support device comprises a chamber 10 formed by a series of panels 34 supported by a support structure 24. The support structure 24 comprises a plurality of ribs 36 arranged in a spiral manner, extending from a first common end 38 and advantageously meeting at a second common end 40 (e.g., as shown in FIG. Figure 8 ). The support structure 24 is configured to collapse and expand (during device insertion) by twisting the walls of the chamber 10 about an axis defined between common endpoints 38, 40. The relative rotation of the chamber walls about the axis may be 45 to 90 degrees, but other rotations are possible.
[0068] In any of the above embodiments, the directional flow structure can be configured as a venturi. The venturi can include a restricted opening at the outlet of the chamber body 10, which includes an inlet cone, a narrowing portion, and an outlet cone. In one example, the inlet cone can include a cone of approximately 30 degrees, and the outlet cone can include a cone of approximately 5 degrees.
[0069] like Fig. 9 As shown, to further optimize the directional flow of blood out of the chamber 10, the restricted opening 22 can be angled relative to the chamber body 10. For example, the chamber body 10 can include a longitudinal axis A, and the restricted opening 22 can include a tube extending along a second axis B that is not coaxial with the first axis A. The angle φ between the restricted opening 22 and the longitudinal axis of the chamber body 10 can be 20 degrees to 50 degrees, more specifically about 35 degrees. This angle allows the chamber body 10 to rest against the left ventricular wall without blocking the mitral valve MV, while still directing blood flow from the chamber 10 directly to the aortic valve AV.
[0070] Methods of providing circulatory assistance including the above-described devices also form part of the present disclosure. For example, the method of providing circulatory assistance includes the following steps: placing the device 10 in a chamber of the heart such that the aperture of the device and associated directional flow components are disposed on the chamber side of the aortic valve in the chamber of the heart. Once placed, the method includes alternately expanding and contracting the dynamic volume body to displace blood in the chamber such that the blood is discharged through the aperture in the direction of the aortic valve.
[0071] The present invention has been described with reference to an exemplary embodiment designed for use with the left ventricle. However, those skilled in the art will appreciate that the invention to which the present disclosure relates may be applied to other chambers of the heart. For example, a cardiac support device according to the present invention may be optimized for use with the right ventricle, and a directional flow structure may direct blood flow away from chamber 10 toward the pulmonary valve. Those skilled in the art will also appreciate that features of one embodiment described herein may be combined with features of one or more additional embodiments. Those skilled in the art will appreciate that other modifications may be made to the exemplary embodiments without departing from the scope of the present invention.
[0072] The present invention also includes the following embodiments:
[0073] Embodiment 1. A cardiac support device for circulatory assistance, the cardiac support device comprising:
[0074] a chamber body (10) defining a chamber having an interior volume configured to be filled with blood, the chamber body (10) having a first opening (12), wherein the chamber body (10) and the first opening (12) are sized to be disposed within a chamber of a human heart;
[0075] a dynamic volume body (14) configured to expand or contract to alternately increase or decrease the internal volume of the chamber;
[0076] a catheter (16) comprising at least one lumen in fluid communication with the dynamic volume body (14) and configured to deliver a fluid to the dynamic volume body to expand the dynamic volume body; and
[0077] A directional flow structure is configured to direct blood flow away from the chamber in a direction substantially aligned with the direction in which the catheter (16) extends.
[0078] Embodiment 2. A cardiac support device according to embodiment 1, wherein the directional flow structure includes a restricted opening (22) which provides a constriction at the first opening (12).
[0079] Embodiment 3. The cardiac support device according to embodiment 1 or embodiment 2 further comprises a support structure (24), wherein the support structure (24) is configured to support the chamber body (10) in an expanded configuration.
[0080] Embodiment 4. A cardiac support device according to embodiment 3, wherein the support structure (24) is foldable.
[0081] Embodiment 5. A cardiac support device according to embodiment 3 or embodiment 4, wherein the support structure (24) is expandable and is provided to be fluidically connected to at least one cavity of the catheter (16) to allow the support structure (24) to expand.
[0082] Embodiment 6. A cardiac support device according to any one of embodiments 1 to 5, wherein the support structure (24) includes a support formed of an elastic material, the support is biased to a second configuration, and can be expanded from a first configuration in which the chamber body (10) has a first internal volume to a second configuration in which the chamber body (10) includes a second internal volume, and the second internal volume is larger than the first internal volume.
[0083] Embodiment 7. A cardiac support device according to embodiment 6, wherein the dynamic volume body (14) is configured to expand the support structure (24) from the first configuration to the second configuration, thereby increasing the internal volume of the chamber (10).
[0084] Embodiment 8. A cardiac support device according to any one of embodiments 1 to 5, wherein the dynamic volume body (14) includes an inflatable balloon (28) disposed within the chamber (10).
[0085] Embodiment 9. A cardiac support device according to Embodiment 8, wherein the balloon (26) is a toroidal balloon (26).
[0086] Embodiment 10. A cardiac support device according to any one of embodiments 1 to 9, wherein the chamber body (10) extends from a proximal end where the first hole (12) is located to a distal end opposite to the proximal end, wherein the balloon (26) is disposed at the distal end of the chamber body (10) and is configured to expand proximally.
[0087] Embodiment 11. A cardiac support device according to any one of embodiments 1 to 10, wherein the chamber body (10) is also provided with one or more additional openings (30), which are arranged at the distal end of the chamber 10, away from the first opening.
[0088] Embodiment 12. A cardiac support device according to embodiment 10, wherein the additional opening (30) is responsible for approximately 5%-10% (e.g. 5%) of the cross-sectional flow area entering / leaving the chamber, and the first opening (12) is responsible for approximately 90%-95% (e.g. 95%).
[0089] Embodiment 13. A cardiac support device according to any one of embodiments 1 to 12, wherein the chamber body (10) may include one or more additional side openings (32) configured to provide additional entrances for blood to enter the interior of the chamber (10).
[0090] Embodiment 14. A cardiac support device according to embodiment 13, wherein the additional opening is configured as a one-way flow opening (32) that allows flow into the interior volume of the chamber (10) and prevents or inhibits flow out of the chamber (10).
[0091] Embodiment 15. A cardiac support device according to any of the preceding embodiments, wherein the device also includes a vortex inducing arrangement.
[0092] Embodiment 16. A cardiac support device according to embodiment 15, wherein the vortex inducing structure includes a plurality of static blades (36) arranged within the restricted opening (22).
[0093] Embodiment 17. A cardiac support device according to any of the preceding embodiments, wherein the chamber body (10) includes a spiral support structure (40) configured to allow the chamber body (10) to be spirally folded.
[0094] Embodiment 18. A cardiac support device according to any of the preceding embodiments, wherein the directional flow structure comprises a venturi tube.
[0095] Embodiment 19. A cardiac support device according to any of the preceding embodiments, wherein the chamber body (10) includes a longitudinal axis (A), and wherein the restricting opening (22) includes a tube extending along a second axis (B), and wherein the first axis and the second axis are not coaxial.
Claims
1. A cardiac support device for circulatory assistance, the cardiac support device comprising: a chamber body (10) defining a chamber having an interior volume configured to be filled with blood, the chamber body (10) having a first opening (12), wherein the chamber body (10) and the first opening (12) are sized to be disposed within a chamber of a human heart; a dynamic volume body (14) configured to expand or contract to alternately increase or decrease the internal volume of the chamber; a catheter (16) comprising at least one lumen in fluid communication with the dynamic volume body (14) and configured to deliver a fluid to the dynamic volume body to expand the dynamic volume body; and a directional flow structure configured to direct blood flow away from the chamber in a direction substantially aligned with the direction in which the conduit (16) extends; and The device also includes a vortex inducing arrangement.
2. A cardiac support device according to claim 1, wherein the directional flow structure includes a restricted opening (22) which provides a constriction at the first opening (12).
3. A cardiac support device according to claim 1 or claim 2, further comprising a support structure (24), wherein the support structure (24) is configured to support the chamber body (10) in an expanded configuration.
4. A cardiac support device according to claim 3, wherein the support structure (24) is foldable.
5. A cardiac support device according to claim 3 or claim 4, wherein the support structure (24) is expandable and is provided to be fluidically connected to at least one cavity of the catheter (16) to allow the support structure (24) to expand.
6. A cardiac support device according to any one of claims 1 to 5, wherein the support structure (24) includes a support formed of an elastic material, which is biased to a second configuration and can be expanded from a first configuration in which the chamber body (10) has a first internal volume to a second configuration in which the chamber body (10) includes a second internal volume, and the second internal volume is larger than the first internal volume.
7. A cardiac support device according to claim 6, wherein the dynamic volume body (14) is configured to expand the support structure (24) from the first configuration to the second configuration, thereby increasing the internal volume of the chamber (10).
8. A cardiac support device according to any one of claims 1 to 5, wherein the dynamic volume body (14) comprises an inflatable balloon (28) disposed within the chamber (10).
9. A cardiac support device according to claim 8, wherein the balloon (26) is a toroidal balloon (26).
10. A cardiac support device according to any one of claims 1 to 9, wherein the chamber body (10) extends from a proximal end where the first hole (12) is located to a distal end opposite to the proximal end, wherein the balloon (26) is disposed at the distal end of the chamber body (10) and is configured to expand proximally.
11. A cardiac support device according to any one of claims 1 to 10, wherein the chamber body (10) is further provided with one or more additional openings (30), which are arranged at the distal end of the chamber 10, away from the first opening.
12. A cardiac support device according to claim 10, wherein the additional opening (30) is responsible for approximately 5%-10% (e.g. 5%) of the cross-sectional flow area entering / leaving the chamber, while the first opening (12) is responsible for approximately 90%-95% (e.g. 95%).
13. A cardiac support device according to any one of claims 1 to 12, wherein the chamber body (10) may include one or more additional side openings (32) configured to provide additional entrances for blood to enter the interior of the chamber (10).
14. A cardiac support device according to claim 13, wherein the additional opening is configured as a one-way flow opening (32) that allows flow into the interior volume of the chamber (10) and prevents or inhibits flow out of the chamber (10).
15. The cardiac support device of claim 1, wherein the vortex inducing structure comprises a plurality of static vanes (36) disposed within the restricted opening (22).
16. A cardiac support device according to any of the preceding claims, wherein the chamber body (10) comprises a helical support structure (40) configured to allow helical folding of the chamber body (10).
17. A cardiac support device according to any of the preceding claims, wherein the directional flow structure comprises a venturi tube.
18. A cardiac support device according to any of the preceding claims, wherein the chamber body (10) includes a longitudinal axis (A), and wherein the restricted opening (22) includes a tube extending along a second axis (B), and wherein the first axis and the second axis are not coaxial.
Citation Information
Patent Citations
Heart impulse assisting system
CN102038979A
Be used for auxiliary vacuum device of pulsatility circulation
CN206228662U
Double balloon pump cardiac assist device and related method of use
US20130184515A1
Heart assist pump
US4964864A
Orthotopic intraventricular heart pump
US5139517A
